Prodotto aggiunto correttamente al carrello.

Triphenyl Methyl Olmesartan

CAS: 144690-92-6 - Triphenyl Methyl Olmesartan

Formula:C48H44N6O6

InChI:InChI=1S/C48H44N6O6/c1-5-17-41-49-43(47(3,4)57)42(45(55)58-31-40-32(2)59-46(56)60-40)53(41)30-33-26-28-34(29-27-33)38-24-15-16-25-39(38)44-50-51-52-54(44)48(35-18-9-6-10-19-35,36-20-11-7-12-21-36)37-22-13-8-14-23-37/h6-16,18-29,57H,5,17,30-31H2,1-4H3

InChI key:InChIKey=IJOPLMOXIPGJIJ-UHFFFAOYSA-N

SMILES:O=C1OC(=C(O1)COC(=O)C2=C(N=C(N2CC=3C=CC(=CC3)C=4C=CC=CC4C5=NN=NN5C(C=6C=CC=CC6)(C=7C=CC=CC7)C=8C=CC=CC8)CCC)C(O)(C)C)C

  • Sinonimi:
  • (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylate
  • 1,3-Dioxole, 1H-imidazole-5-carboxylic acid deriv.
  • 1H-Imidazole-5-carboxylic acid,4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-,(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
  • 5-Methoxy-2-oxo-1,3-dioxol-4-yl) methyl-4-(1-hydroxy-1-methylethyl-2 propyl-1-(2-(2-triphenylmethyl)-2H-tetrazole-5-yl) biphenyl-4-yl) methyl)-1H-imidazole-5-carboxylate
  • Omst-C
  • Trityl Olmesartan Medoximil (N-1)
  • Trityl Olmesartan Medoxomil
  • Trityl olmesartan
  • Tritylolmesartan medoxomil
Ordinare per


Vedere altre categorie

Questa ricerca non contiene alcuna categoria.

2 prodottitrovati.

discount label

Ref: AN-AG001K06

1g34,00 €
5g61,00 €
Consegna stimata in Stati Uniti, il Venerdì 10 Maggio 2024
discount label

4-(1-Hydroxy-1-methylethyl)-2-propyl-1[4-[2-(trityltetrazol-5-yl)phenyl]phenyl]methylimidazo-5-carboxylate (5-methyl-2-oxo-1,3-dioxo len-4-yl)methyl

CAS:144690-92-6

Ref: 3D-IH57932

2g63,00 €
5g97,00 €
10g138,00 €
25g194,00 €
50g348,00 €
Consegna stimata in Stati Uniti, il Venerdì 05 Luglio 2024
Benvenuto su CymitQuimica!Utilizziamo i cookie per migliorare la tua visita. Non includiamo pubblicità.

Consulta la nostra Politica sui Cookie per maggiori dettagli o regola le tue preferenze in "Configura".